UK markets closed

Select Medical Holdings Corporation (SEM)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
28.07+0.09 (+0.32%)
As of 12:57PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.59B
Enterprise value 8.41B
Trailing P/E 14.65
Forward P/E 13.68
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.52
Price/book (mrq)2.79
Enterprise value/revenue 1.26
Enterprise value/EBITDA 10.65

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3-3.58%
S&P500 52-week change 323.57%
52-week high 333.51
52-week low 321.28
50-day moving average 328.24
200-day moving average 326.43

Share statistics

Avg vol (3-month) 3506.29k
Avg vol (10-day) 3456.4k
Shares outstanding 5128.36M
Implied shares outstanding 6130.54M
Float 8104.02M
% held by insiders 117.27%
% held by institutions 178.82%
Shares short (15 Apr 2024) 42.28M
Short ratio (15 Apr 2024) 44.45
Short % of float (15 Apr 2024) 43.45%
Short % of shares outstanding (15 Apr 2024) 41.77%
Shares short (prior month 15 Mar 2024) 42.52M

Dividends & splits

Forward annual dividend rate 40.5
Forward annual dividend yield 41.79%
Trailing annual dividend rate 30.50
Trailing annual dividend yield 31.79%
5-year average dividend yield 4N/A
Payout ratio 426.18%
Dividend date 313 Mar 2024
Ex-dividend date 429 Feb 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 3.65%
Operating margin (ttm)6.96%

Management effectiveness

Return on assets (ttm)4.52%
Return on equity (ttm)20.22%

Income statement

Revenue (ttm)6.66B
Revenue per share (ttm)54.13
Quarterly revenue growth (yoy)4.90%
Gross profit (ttm)N/A
EBITDA 763.62M
Net income avi to common (ttm)234.72M
Diluted EPS (ttm)1.91
Quarterly earnings growth (yoy)68.20%

Balance sheet

Total cash (mrq)142.97M
Total cash per share (mrq)1.11
Total debt (mrq)4.96B
Total debt/equity (mrq)315.09%
Current ratio (mrq)1.01
Book value per share (mrq)10.04

Cash flow statement

Operating cash flow (ttm)582.06M
Levered free cash flow (ttm)292.92M